M&A Deal Summary

Guerbet Acquires Mallinckrodt - Contrast Media And Delivery Systems Imaging Business

On November 27, 2015, Guerbet acquired medical products company Mallinckrodt - Contrast Media And Delivery Systems Imaging Business from Mallinckrodt for 270M USD

Acquisition Highlights
  • This is Guerbet’s 1st transaction in the Medical Products sector.
  • This is Guerbet’s largest (disclosed) transaction.
  • This is Guerbet’s 1st transaction in the United States.

M&A Deal Summary
Date 2015-11-27
Target Mallinckrodt - Contrast Media And Delivery Systems Imaging Business
Sector Medical Products
Buyer(s) Guerbet
Sellers(s) Mallinckrodt
Deal Type Divestiture
Deal Value 270M USD

Target

Mallinckrodt - Contrast Media And Delivery Systems Imaging Business

United States
Mallinckrodt's CMDS business manufactures and markets a comprehensive array of diagnostic imaging products engineered to work across the radiology suite – computed tomography, magnetic resonance imaging, X-ray and cardiac catheterization – as well as the company's urological imaging system and related components.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Guerbet

Villepinte, France
Category Company
Founded 1926
Sector Medical Products
Employees2,920
Revenue 796M EUR (2023)
DESCRIPTION

Guerbet is a manufacture of medical imaging products. Guerbet was founded in 1926 and is based in Villepinte, France.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2015) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Mallinckrodt

Dublin, United Kingdom
Category Company
Founded 1867
Sector Life Science
Employees2,673
Revenue 2.2B USD (2021)
DESCRIPTION

Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. Mallinckrodt was founded in 1867 and is based in Dublin, Ireland.

DEAL STATS #
Overall 2 of 7
Sector (Medical Products) 1 of 4
Type (Divestiture) 2 of 7
Country (United States) 1 of 2
Year (2015) 1 of 1
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-10 Therakos

West Chester, Pennsylvania, United States

Therakos is a fully integrated extracorporeal photopheresis (ECP) delivery system for autologous immunomodulatory therapy. Therakos is based in West Chester, Pennsylvania.

Buy $1.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-18 Medicines Company - Hemostasis Products

United States

Medicines Company - Hemostasis Products are RECOTHROM Thrombin topical (Recombinant), PreveLeak, and RAPLIXA (fibrin sealant) products used for blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques.

Buy $175M
Mergr

Product

Company

Legal